Michigan Cancer Research Consortium
In research, Michigan Cancer Research Consortium stands highest in Medicine (#7,403 of 17,978 worldwide) and Health Sciences (#9,549 of 20,462 worldwide), over all time.
- World rank, all time
- #16,698 of 42,892
- Rank in United States
- #3,630 of 8,685
- Research works
- 225 ▲ 27% vs 2013–17
- Citations
- 7.7k 34.0 per fractional work
- Top-10% rate
- 15.6% record average 16.5%
- Open access
- 48% world 28%
What is Michigan Cancer Research Consortium known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #7,403 of 17,978 | 22.9% | 120 | |
| Health SciencesDomain | #9,549 of 20,462 | 24.2% | 130 |
Each strip is that field’s whole ranked pool, with the notch where Michigan Cancer Research Consortium sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.
- Medicine 3.5×
- Immunology and Microbiology 3.3×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Economics, Econometrics and Finance 2.1×
- Pharmacology, Toxicology and Pharmaceutics 1.8×
- Health Professions 0.8×
- Dentistry 0.6×
- Neuroscience 0.6×
- Chemistry 0.6×
- Decision Sciences 0.5×
- Psychology 0.3×
- Mathematics 0.2×
- Environmental Science 0.2×
- Social Sciences 0.1×
- Materials Science 0.1×
- Arts and Humanities 0.1×
- Engineering 0.1×
- Computer Science 0.1×
- Physics and Astronomy 0.1×
- Earth and Planetary Sciences 0.1×
- Agricultural and Biological Sciences 0.0×
Which keywords describe research at Michigan Cancer Research Consortium?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Prognostic Factors, Cancer, Breast Cancer, Health-related Quality of Life, Tumor Microenvironment and Quality of Life.
- Minimal Residual Disease
- CAR T Cells
- Precision Medicine
- Neoadjuvant Therapy
- Genomic Profiling
- Tumor Regression
- Mesenchymal Stem Cells
- Clinical Practice Guidelines
- Genetic Testing
- Hematopoietic Stem Cells
- Lymphoma
- Targeted Therapy
- Patient-Reported Outcomes
- Anxiety
- Cancer Survivorship
- Cost of Care
- Tumor Microenvironment
- Breast Cancer
- Prognostic Factors
- Cancer
- Chemotherapy
- Immunotherapy
- Quality of Life
- Health-related Quality of Life
- Inflammation
- Financial Toxicity
- Depression
- Clinical Trials
- Physical Activity
- Radiotherapy
- Cancer Risk
- Cancer Therapy
- Cancer Immunotherapy
- Genetic Mutations
- Molecular Characterization
- Complications
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Rituximab
- Chimeric Antigen Receptor
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy5▲ 13×20 topics
- Cancer4▲ 5.2×28 topics
- Immunotherapy3▲ 8.4×13 topics
- Prognostic Factors3▲ 14×10 topics
- Quality of Life3▲ 4.0×11 topics
- Breast Cancer2▲ 20×8 topics
- Health-related Quality of Life2▲ 18×3 topics
- Tumor Microenvironment2▲ 9.7×8 topics
- Inflammation2▲ 1.97×20 topics
- Cost of Care2▲ 126×1 topic
- Financial Toxicity2▲ 126×1 topic
- Cancer Survivorship2▲ 49×2 topics
- Depression2▲ 4.2×5 topics
- Anxiety2▲ 7.1×2 topics
- Clinical Trials2▲ 5.0×7 topics
- Patient-Reported Outcomes2▲ 61×1 topic
- Physical Activity2▲ 6.6×1 topic
- Targeted Therapy2▲ 13×4 topics
- Radiotherapy2▲ 7.5×10 topics
- Lymphoma2▲ 17×2 topics
- Cancer Risk1▲ 11×4 topics
- Hematopoietic Stem Cells1▲ 30×3 topics
- Cancer Therapy1▲ 4.3×9 topics
- Genetic Testing1▲ 21×3 topics
- Cancer Immunotherapy1▲ 14×2 topics
- Clinical Practice Guidelines1▲ 3.8×7 topics
- Genetic Mutations1▲ 5.2×10 topics
- Mesenchymal Stem Cells1▲ 21×2 topics
- Molecular Characterization1▲ 12×5 topics
- Tumor Regression1▲ 21×2 topics
- Complications1▲ 4.0×6 topics
- Genomic Profiling1▲ 19×2 topics
- Immune Checkpoint Blockade1▲ 18×1 topic
- Neoadjuvant Therapy1▲ 8.2×5 topics
- PD-1 and PD-L11▲ 18×1 topic
- Precision Medicine1▲ 4.3×3 topics
- Rituximab1▲ 13×2 topics
- CAR T Cells1▲ 25×1 topic
- Chimeric Antigen Receptor1▲ 25×1 topic
- Minimal Residual Disease1▲ 27×2 topics
Which research topics does Michigan Cancer Research Consortium publish most on?
By volume in 2022–2025: Economic and Financial Impacts of Cancer, Cancer survivorship and care, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 2 Cancer survivorship and care Oncology 2 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 4 CAR-T cell therapy research Oncology 1 works
- 5 Medication Adherence and Compliance Family Practice 1 works
- 6 Cancer-related cognitive impairment studies Pulmonary and Respiratory Medicine 1 works
- 7 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 1 works
- 8 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 1 works
- 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 10 BRCA gene mutations in cancer Genetics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Michigan Cancer Research Consortium's research output changed?
Output in 2018–2022 was 27% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ann Arbor
- University of Michigan
- Michigan Medicine
- Ann Arbor Center for Independent Living
- Ann Arbor VA Medical Center
- VA Ann Arbor Healthcare System
- C. S. Mott Children's Hospital
- Environmental Research Institute of Michigan
- Women's Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.